Tag: Healthcare

news-13102024-072210

Expanding Harris’ Medicare at Home Plan to Better Serve Seniors

Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker,...
unitedhealths-a-care-denials-lawsuit-allowed-to-proceed

UnitedHealth’s AI care denials lawsuit allowed to proceed

In a recent turn of events, Medicare Advantage beneficiaries who believe they were wrongfully denied care by UnitedHealth Group's algorithm have reason to celebrate. A judge ruled that their case can proceed, potentially shedding...
the-main-target-and-focus-the-article-focuses-on-key-figures-attending-the-jp-morgan-healthcare-conference-on-day-2new-title-highlights-from-jp-morgan-healthcare-conference-day-2

The Main Target and Focus: The article focuses on key figures attending the J.P....

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
narcan-over-the-counter-lifesaving-opioid-overdose-reversal-drug

Narcan: Over-the-Counter Lifesaving Opioid Overdose Reversal Drug

Narcan: The Groundbreaking Over-the-Counter Opioid Overdose Reversal DrugThe Food and Drug Administration has taken a monumental step in the fight against opioid overdoses by approving Narcan, a life-saving naloxone nasal spray, for over-the-counter use....
fda-approval-onis-rare-disease-therapy-lowers-triglycerides

FDA Approval: Ionis Rare Disease Therapy Lowers Triglycerides

Ionis Pharmaceuticals has achieved a significant milestone by obtaining FDA approval for their groundbreaking therapy, Tryngolza, designed to combat a rare and fatal genetic disease. This therapy targets patients suffering from familial chylomicronemia syndrome...
news-12082024-194709

Pfizer CEO’s Vision for Leading Cancer and Obesity Treatments

Albert Bourla, the CEO of Pfizer, is looking to shift the focus of the company from its successful COVID-19 vaccine and antiviral Paxlovid to new investments in drugs for cancer and obesity. While Pfizer's...
news-20112024-002106

Dr. Oz appointed by Trump to head Medicare and Medicaid

President-elect Trump has chosen Dr. Mehmet Oz, a well-known surgeon and television personality, to lead the Centers for Medicare and Medicaid Services. This agency plays a crucial role in setting policies that affect payments...
news-19102024-210648

Impact of U.S. Election on Medicare, Drug Pricing, and AI

Health care is a significant topic in the upcoming U.S. election, with leaders from different political backgrounds sharing their views on various health care issues at STAT's Summit. Among the topics discussed were Medicare,...
news-06112024-052955

Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees

Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
threat-to-pharmaceutical-public-private-partnerships-gileads-short-term-win

Threat to Pharmaceutical Public-Private Partnerships: Gilead’s Short-Term Win

In December 2024, a group of legal, medical, and public health experts united to file an amicus brief in support of the U.S. government in a groundbreaking patent lawsuit against Gilead Sciences Inc., a...
understanding-palliative-care-nsights-from-a-professional-nh-medlineplus-magazine

Understanding Palliative Care: Insights from a Professional | NIH MedlinePlus Magazine

Understanding Palliative Care: A Compassionate GuideIn the realm of healthcare, when serious or terminal illnesses strike, patients and their families are often left grappling with difficult decisions and overwhelming emotions. The vast array of...
news-26112024-175408

Reining in AI Use in Medicare Advantage: Biden Administration’s Plan

The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence, and ensuring access to behavioral health providers and additional benefits....